similarly found lower IGF-1 levels in patients with cancer (797 ± 353 ng/mL) versus those without (923 ± 385 ng/mL, p = 0.001), while GH did not differ significantly (10.61 vs. 10.9 ng/mL, p = 0.31). This evidence concerns the gene IGF1 and cancer.